NovaBridge Biosciences NBP US Equity☆

NovaBridge Biosciences (Nasdaq: NBP), an SEC filer in Pharmaceutical Preparations, closed at $1.89, +1.1%, on 2026-08-27, with a return on equity of -21.4%. Institutional ownership, earnings history and filed financials are on the tabs below.

Item 3 and Item 9A are read from original 10-Ks. Foreign filers (20-F / ESEF / EDINET) file none, so this read covers US SEC filers.